top of page
Technology
LifeMatrix develops a unique bio-engineering technology to grow human replacement tissues in the laboratory as next generation implants for the treatment of cardiovascular diseases.
About us
LifeMatrix Technologies AG, is a pre-revenue, high-tech startup company spun out of the Institute for Regenerative Medicine at the University of Zurich.
Press & News
Award winning technology
Active in the field of biomimetic implants, LifeMatrix develops human cell derived, off-the-shelf available tissue engineered implants, which transform into living tissue after implantation and have the capacity to grow and regenerate with the patient.
The award winning technology is the result of multiple national and international research grants and is backed by more than 20 years of research with over 100 peer-reviewed publications.
Extensive preclinical (animal) studies demonstrated safety and efficacy and allow the technology to be translated in to clinical application.
bottom of page